Pancreatic Cancer Research

ResearcherUniversitätsklinikum ErlangenNo recent work listed

Siyuan Zeng

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-0537-4808. Sources: OpenAlex.

Their work

Papers
3 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
11
Papers, trials and grants by year

2019: 2 papers · 2020: none · 2021: none · 2022: 1 paper

Papers 3

  1. CDK7 inhibition augments response to multidrug chemotherapy in pancreatic cancer. Co-author DOI 10.1186/s13046-022-02443-w↗
  2. The Role of Exosomes in Pancreatic Cancer. First author DOI 10.3390/ijms20184332↗
  3. Chemoresistance in Pancreatic Cancer. Co-author DOI 10.3390/ijms20184504↗

Closest collaborators

The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Bin Lan · 3 shared papers, 2019–2022 · strength 0.38
  2. Robert Grützmann · 3 shared papers, 2019–2022 · strength 0.38
  3. Christian P. Pilarsky · 3 shared papers, 2019–2022 · strength 0.38
  4. Hai Yang · 2 shared papers, 2019–2022 · strength 0.24
  5. Nathalie Britzen‐Laurent · 1 shared paper, 2022 · strength 0.13
  6. Peter J. Bailey · 1 shared paper, 2022 · strength 0.13
  7. Daniel Schreyer · 1 shared paper, 2022 · strength 0.13
  8. Shuman Zhang · 1 shared paper, 2022 · strength 0.13
  9. David Kuang-Fu Chang · 1 shared paper, 2022 · strength 0.13
  10. Debabrata Mukhopadhyay · 1 shared paper, 2022 · strength 0.13
  11. Andrew Victor Biankin · 1 shared paper, 2022 · strength 0.13

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.